1. The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia.
- Author
-
Heshmati Y, Türköz G, Harisankar A, Kharazi S, Boström J, Dolatabadi EK, Krstic A, Chang D, Månsson R, Altun M, Qian H, and Walfridsson J
- Subjects
- Biomarkers, Cell Line, Cell Proliferation, Disease Progression, Hematopoiesis genetics, Hematopoietic Stem Cells metabolism, Humans, Leukemia, Myeloid, Acute metabolism, Leukemia, Myeloid, Acute pathology, Mi-2 Nucleosome Remodeling and Deacetylase Complex metabolism, Myeloid-Lymphoid Leukemia Protein genetics, Neoplastic Stem Cells metabolism, Oncogene Proteins, Fusion genetics, RNA Interference, RNA, Messenger genetics, RNA, Small Interfering genetics, Transcriptome, Tumor Cells, Cultured, Chromatin Assembly and Disassembly, Leukemia, Myeloid, Acute genetics, Mi-2 Nucleosome Remodeling and Deacetylase Complex genetics
- Abstract
Epigenetic alterations contribute to leukemogenesis in childhood acute myeloid leukemia and therefore are of interest for potential therapeutic strategies. Herein, we performed large-scale ribonucleic acid interference screens using small hairpin ribonucleic acids in acute myeloid leukemia cells and non-transformed bone marrow cells to identify leukemia-specific dependencies. One of the target genes displaying the strongest effects on acute myeloid leukemia cell growth and less pronounced effects on nontransformed bone marrow cells, was the chromatin remodeling factor CHD4 Using ribonucleic acid interference and CRISPR-Cas9 approaches, we showed that CHD4 was essential for cell growth of leukemic cells in vitro and in vivo Loss of function of CHD4 in acute myeloid leukemia cells caused an arrest in the G0 phase of the cell cycle as well as downregulation of MYC and its target genes involved in cell cycle progression. Importantly, we found that inhibition of CHD4 conferred anti-leukemic effects on primary childhood acute myeloid leukemia cells and prevented disease progression in a patient-derived xenograft model. Conversely, CHD4 was not required for growth of normal hematopoietic cells. Taken together, our results identified CHD4 as a potential therapeutic target in childhood acute myeloid leukemia., (Copyright© 2018 Ferrata Storti Foundation.)
- Published
- 2018
- Full Text
- View/download PDF